Tamaskani Narges, Khandashpour Mahmoud, Livani Somayeh
1.Clinical Research Development Center (CRDC), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran.
Caspian J Intern Med. 2021;12(Suppl 2):S368-S370. doi: 10.22088/cjim.12.0.368.
We encountered the novel coronavirus infection as a pandemic in 2020. The infection started in Wuhan, China, and spread rapidly all over the world. CT scan has been used as an important diagnostic method in the detection of suspicious patients. One of the uncommon complications of coronavirus disease 2019 (COVID-19) is pneumothorax.
A 47-year-old smoker male with COVID-19 diagnosis, good general condition and no respiratory complaint, complicated by pneumothorax. He refused hospitalization. After educating him about the red flags and quarantine protocols, he continued treatment at home .Cap amoxicillin/clavulanic acid 625mg was prescribed for one week. A follow-up CT represented only small involvement of lungs. Pneumothorax was resolved spontaneously without any medical intervention and hospitalization. O saturation was in normal range an there was no dry cough anymore.
According to our clinical experience, pneumothorax is resolved spontaneously in a COVID-19 case. Considering general status and hemodynamic stability, it is suggested to reduce invasive interventions in COVID-19 cases with pneumothorax.
2020年，我们遭遇了新型冠状病毒感染的大流行。该感染始于中国武汉，并迅速蔓延至全球。CT扫描已被用作检测可疑患者的重要诊断方法。2019冠状病毒病（COVID-19）的罕见并发症之一是气胸。
一名47岁的男性吸烟者，被诊断为COVID-19，一般状况良好，无呼吸道症状，并发气胸。他拒绝住院。在向他介绍了危险信号和隔离方案后，他继续在家接受治疗。开具了阿莫西林/克拉维酸625毫克，服用一周。后续CT显示肺部仅有轻微受累。气胸未经任何医疗干预和住院治疗便自行消退。血氧饱和度在正常范围内，不再有干咳。
根据我们的临床经验，COVID-19病例中的气胸可自行消退。考虑到一般状况和血流动力学稳定性，建议减少对并发气胸的COVID-19病例的侵入性干预。
